Atlas Trials

Neoadjuvant Immunotherapy in Brain Metastases

Clinical trial NCT04434560 · TERMINATED

Trial details

NCT number
NCT04434560
Sponsor
Sarah Sammons, MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Metastases, Adult
Start date
2020-11-04
Primary completion
2021-06-17
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.